Elmind Capital, LP
NEW YORK, NY · CIK 2052213 · 13F filing filed 2026-08-14
SEC-registered investment adviser since 2024 · limited partnership
- Assets managed$613.6m
- Staff2 · 1 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds1 (1 hedge) · $613.6m gross assets
- Form ADV · 2026-09-03SEC adviser record
- Legal entityELMIND CAPITAL, LP (US)
$398.0m
reported value
+13.0% vs Q1 2026
35positions
66.6%in top 10
6 new
9 added
6 reduced
5 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| COGENT BIOSCIENCES INC COGT | $45.3m11.38% | Unchanged |
| SYNDAX PHARMACEUTICALS INC SNDX | $40.6m10.19% | Unchanged |
| CELLDEX THERAPEUTICS INC NEW CLDX | $36.8m9.25% | Added +125.0k |
| RELAY THERAPEUTICS INC RLAY | $27.4m6.89% | Added +928.3k |
| VAXCYTE INC PCVX | $26.3m6.61% | Added +135.8k |
| VERA THERAPEUTICS INC VERA | $18.7m4.71% | Reduced -46.0k |
| PHARVARIS N V PHVS | $18.2m4.57% | Added +50.0k |
| VIRIDIAN THERAPEUTICS INC VRDN | $18.1m4.55% | Added +450.0k |
| CYTOMX THERAPEUTICS INC CTMX | $17.1m4.29% | Unchanged |
| TRAVERE THERAPEUTICS INC TVTX | $16.6m4.18% | Added +115.0k |
| LEGEND BIOTECH CORP LEGN | $16.5m4.14% | New |
| BEAM THERAPEUTICS INC BEAM | $16.3m4.11% | Unchanged |
| CULLINAN THERAPEUTICS INC CGEM | $12.6m3.16% | Added +160.0k |
| NURIX THERAPEUTICS INC NRIX | $11.2m2.80% | Unchanged |
| KRYSTAL BIOTECH INC KRYS | $8.2m2.05% | Unchanged |
| UNITED THERAPEUTICS CORP DEL UTHR | $8.1m2.04% | Unchanged |
| SUMMIT THERAPEUTICS INC SMMT | $7.2m1.81% | New |
| INSMED INC INSM | $6.9m1.74% | New |
| BIOCRYST PHARMACEUTICALS INC BCRX | $5.2m1.31% | Reduced -480.0k |
| MBX BIOSCIENCES INC MBX | $5.0m1.26% | Reduced -120.0k |
| PROTAGONIST THERAPEUTICS INC PTGX | $4.7m1.17% | Unchanged |
| UROGEN PHARMA LTD URGN | $4.4m1.11% | Reduced -100.0k |
| DBV TECHNOLOGIES S A DBVT | $4.3m1.09% | Unchanged |
| ALUMIS INC ALMS | $3.7m0.92% | Unchanged |
| SUPERNUS PHARMACEUTICALS INC SUPN | $3.3m0.82% | Added +50.0k |
| BIOMARIN PHARMACEUTICAL INC BMRN | $2.7m0.68% | Unchanged |
| IMMUNOCORE HLDGS PLC IMCR | $2.6m0.65% | Added +22.9k |
| AMYLYX PHARMACEUTICALS INC AMLX | $2.0m0.51% | Unchanged |
| ALECTOR INC ALEC | $1.8m0.45% | Unchanged |
| SEPTERNA INC SEPN | $1.7m0.42% | New |
| DESIGN THERAPEUTICS INC DSGN | $1.6m0.39% | Reduced -100.0k |
| SUTRO BIOPHARMA INC STRO | $1.1m0.27% | New |
| WAVE LIFE SCIENCES LTD 96663EUR | $1.0m0.26% | Unchanged |
| TYRA BIOSCIENCES INC TYRA | $638.8k0.16% | Reduced -330.0k |
| ENGENE THERAPEUTICS INC ENGN | $363.3k0.09% | New |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| KALVISTA PHARMACEUTICALS INC KALV | $20.6m1.0m shares |
| CG ONCOLOGY INC CGON | $19.7m291.8k shares |
| APELLIS PHARMACEUTICALS INC APLS | $2.0m50.0k shares |
| ENGENE HOLDINGS INC | $1.4m210.0k shares |
| EDGEWISE THERAPEUTICS INC EWTX | $315.0k10.0k shares |